Literature DB >> 23193974

The action of cytochrome b(5) on CYP2E1 and CYP2C19 activities requires anionic residues D58 and D65.

Hwei-Ming Peng1, Richard J Auchus.   

Abstract

The capacity of cytochrome b(5) (b(5)) to influence cytochrome P450 activities has been extensively studied and physiologically validated. Apo-b(5) enhances the activities of CYP3A4, CYP2A6, CYP2C19, and CYP17A1 but not that of CYP2E1 or CYP2D6, suggesting that the b(5) interaction varies among P450s. We previously showed that b(5) residues E48 and E49 are required to stimulate the 17,20-lyase activity of CYP17A1, but these same residues might not mediate b(5) activation of other P450 reactions, such as CYP2E1-catalyzed oxygenations, which are insensitive to apo-b(5). Using purified P450, b(5), and reductase (POR) in reconstituted assays, the D58G/D65G double mutation, of residues located in a hydrophilic α-helix of b(5), totally abolished the ability to stimulate CYP2E1-catalyzed chlorzoxazone 6-hydroxylation. In sharp contrast, the D58G/D65G double mutation retained the full ability to stimulate the 17,20-lyase activity of CYP17A1. The D58G/D65G double mutation competes poorly with wild-type b(5) for binding to the CYP2E1·POR complex yet accepts electrons from POR at a similar rate. Furthermore, the phospholipid composition markedly influences P450 turnover and b(5) stimulation and specificity, particularly for CYP17A1, in the following order: phosphatidylserine > phosphatidylethanolamine > phosphatidylcholine. The D58G/D65G double mutation also failed to stimulate CYP2C19-catalyzed (S)-mephenytoin 4-hydroxylation, whereas the E48G/E49G double mutation stimulated these activities of CYP2C19 and CYP2E1 equivalent to wild-type b(5). We conclude that b(5) residues D58 and D65 are essential for the stimulation of CYP2E1 and CYP2C19 activities and that the phospholipid composition significantly influences the b(5)-P450 interaction. At least two surfaces of b(5) differentially influence P450 activities, and the critical residues for individual P450 reactions cannot be predicted from sensitivity to apo-b(5) alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193974      PMCID: PMC3596112          DOI: 10.1021/bi301384n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  High-level expression in Escherichia coli and purification of the membrane-bound form of cytochrome b(5).

Authors:  S B Mulrooney; L Waskell
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

2.  Stimulation of cytochrome P450 reactions by apo-cytochrome b5: evidence against transfer of heme from cytochrome P450 3A4 to apo-cytochrome b5 or heme oxygenase.

Authors:  H Yamazaki; T Shimada; M V Martin; F P Guengerich
Journal:  J Biol Chem       Date:  2001-06-18       Impact factor: 5.157

3.  Developmental changes in steroidogenic enzymes in human postnatal adrenal cortex: immunohistochemical studies.

Authors:  T Suzuki; H Sasano; J Takeyama; C Kaneko; W A Freije; B R Carr; W E Rainey
Journal:  Clin Endocrinol (Oxf)       Date:  2000-12       Impact factor: 3.478

4.  Interaction of apo-cytochrome b5 with cytochromes P4503A4 and P45017A: relevance of heme transfer reactions.

Authors:  O L Guryev; A A Gilep; S A Usanov; R W Estabrook
Journal:  Biochemistry       Date:  2001-04-24       Impact factor: 3.162

Review 5.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

6.  Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.

Authors:  Hiroshi Yamazaki; Mami Nakamura; Tomoko Komatsu; Katsuhiro Ohyama; Naoya Hatanaka; Satoru Asahi; Noriaki Shimada; F Peter Guengerich; Tsutomu Shimada; Miki Nakajima; Tsuyoshi Yokoi
Journal:  Protein Expr Purif       Date:  2002-04       Impact factor: 1.650

Review 7.  Adrenarche - physiology, biochemistry and human disease.

Authors:  Richard J Auchus; William E Rainey
Journal:  Clin Endocrinol (Oxf)       Date:  2004-03       Impact factor: 3.478

8.  CYP17 mutation E305G causes isolated 17,20-lyase deficiency by selectively altering substrate binding.

Authors:  Daniel P Sherbet; Dov Tiosano; Kerri M Kwist; Zeev Hochberg; Richard J Auchus
Journal:  J Biol Chem       Date:  2003-09-22       Impact factor: 5.157

Review 9.  The many roles of cytochrome b5.

Authors:  John B Schenkman; Ingela Jansson
Journal:  Pharmacol Ther       Date:  2003-02       Impact factor: 12.310

Review 10.  Cytochrome P450: what have we learned and what are the future issues?

Authors:  F Peter Guengerich
Journal:  Drug Metab Rev       Date:  2004-05       Impact factor: 4.518

View more
  13 in total

Review 1.  Correlating structure and function of drug-metabolizing enzymes: progress and ongoing challenges.

Authors:  Eric F Johnson; J Patrick Connick; James R Reed; Wayne L Backes; Manoj C Desai; Lianhong Xu; D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  Drug Metab Dispos       Date:  2013-10-15       Impact factor: 3.922

2.  A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.

Authors:  Mariana Garrido; Hwei-Ming Peng; Francis K Yoshimoto; Sunil K Upadhyay; Eugene Bratoeff; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2014-02-06       Impact factor: 4.292

3.  Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.

Authors:  Hwei-Ming Peng; Jiayan Liu; Sarah E Forsberg; Hong T Tran; Sean M Anderson; Richard J Auchus
Journal:  J Biol Chem       Date:  2014-10-14       Impact factor: 5.157

4.  Structural and functional effects of cytochrome b5 interactions with human cytochrome P450 enzymes.

Authors:  Aaron G Bart; Emily E Scott
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

5.  Phosphorylation of human cytochrome P450c17 by p38α selectively increases 17,20 lyase activity and androgen biosynthesis.

Authors:  Meng Kian Tee; Walter L Miller
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

6.  Substrate-modulated cytochrome P450 17A1 and cytochrome b5 interactions revealed by NMR.

Authors:  D Fernando Estrada; Jennifer S Laurence; Emily E Scott
Journal:  J Biol Chem       Date:  2013-04-25       Impact factor: 5.157

7.  Two surfaces of cytochrome b5 with major and minor contributions to CYP3A4-catalyzed steroid and nifedipine oxygenation chemistries.

Authors:  Hwei-Ming Peng; Richard J Auchus
Journal:  Arch Biochem Biophys       Date:  2013-11-17       Impact factor: 4.013

8.  Effect of Gambogenic Acid on Cytochrome P450 1A2, 2B1 and 2E1, and Constitutive Androstane Receptor in Rats.

Authors:  Jing Sun; Xiaozhu Tang; Qianqian Xu; Tao Ge; Daiyin Peng; Weidong Chen
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

9.  Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.

Authors:  Hwei-Ming Peng; Chase Barlow; Richard J Auchus
Journal:  J Steroid Biochem Mol Biol       Date:  2018-03-13       Impact factor: 4.292

10.  Cytochrome b5 Activates the 17,20-Lyase Activity of Human Cytochrome P450 17A1 by Increasing the Coupling of NADPH Consumption to Androgen Production.

Authors:  Hwei-Ming Peng; Sang-Choul Im; Naw May Pearl; Adina F Turcu; Juilee Rege; Lucy Waskell; Richard J Auchus
Journal:  Biochemistry       Date:  2016-07-29       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.